The complex interrelationships between chronic lung and liver disease: a review

Area of Science:

• Pulmonology and Hepatology
• Internal Medicine

Background:

• Hepatic disease can lead to a wide spectrum of lung complications, varying in severity and often challenging to diagnose.
• Pathogenesis involves alterations in cytokine production/clearance, affecting conditions like hepatopulmonary syndrome and portopulmonary hypertension.
• Congenital, inflammatory, and drug-induced disorders can affect both liver and lung simultaneously.

Purpose of the Study:

• To review diagnostic and therapeutic strategies for lung complications associated with hepatic disease.
• To emphasize the importance of early recognition and referral for accurate diagnosis and management.
• To highlight the benefits of a multidisciplinary approach involving pulmonologists, hepatologists, and transplant surgeons.

Main Methods:

• Literature review of recent studies on pulmonary manifestations of hepatic disease.
• Summary of diagnostic challenges and therapeutic considerations.
• Emphasis on multidisciplinary team collaboration.

Main Results:

• Lung complications of hepatic disease are heterogeneous, with unpredictable severity relative to liver impairment.
• Cytokine therapy can cause pulmonary and hepatic toxic effects, potentially leading to disease reactivation upon discontinuation.
• Early referral to specialized centers improves patient outcomes.

Conclusions:

• Early diagnosis and management of lung complications in hepatic disease are critical to prevent severe sequelae.
• A coordinated, multidisciplinary approach is essential for optimal patient care.
• Specialized expertise is crucial for managing these complex and often misdiagnosed conditions.